Multiple restriction enzyme digests are required to rule out polymorphism in the molecular diagnosis of chronic myeloid leukemia
Grossman, A.; Mathew, A.; O'Connell, M.P.; Tiso, P.; Distenfeld, A.; Benn, P.
Leukemia 4(1): 63-64
1990
ISSN/ISBN: 0887-6924 PMID: 1967323 Document Number: 348332
Document emailed within 1 workday
Related Documents
Glenn, T.C.; Waller, D.R.; Braun, M.J. 1994: Increasing proportions of uracil in DNA substrates increases inhibition of restriction enzyme digests Biotechniques 17(6): 1086-1090Hernández, A.; Corral, L.; Muñiz, A.; Aláez, C.; Martínez, G. 1991: Atypical chronic myeloid leukemia with polymorphism of the BCR gene Sangre 36(6): 497-499
Sasaki, K.; Mitani, K. 2009: Molecular pathogenesis of chronic myeloid leukemia Nihon Rinsho. Japanese Journal of Clinical Medicine 67(10): 1894-1899
Tsuji-Takayama, K.; Kamiya, T.; Nakamura, S.; Matsuo, Y.; Adachi, T.; Tsubota, T.; Imanishi, J.; Minowada, J. 1994: Establishment of multiple leukemia cell lines with diverse myeloid and/or megakaryoblastoid characteristics from a single Ph1 positive chronic myelogenous leukemia blood sample Human Cell 7(3): 167-171
Cervantes, F. 1993: Molecular biology studies in chronic myeloid leukemia Medicina Clinica 101(14): 538-540
Kajtár, B.él.; Méhes, G.áb.; Jaksó, P.ál.; Kereskai, L.ás.ó; Iványi, J.án.L.ás.ó; Losonczy, H.; Egyed, M.ós.; Tóth, P.ét.; Tóth, A.; Gasztonyi, Z.án.; Dömötör, M.ár.; Pajor, L.ás.ó 2006: Cytogenetic and molecular monitoring of chronic myeloid leukemia Orvosi Hetilap 147(21): 963-970
Michalová, K.; Zemanová, Z.; Haskovec, C.; Rypácková, B.; Brdicka, R. 1992: Use of cytogenetic and molecular biology in the detection of chronic myeloid leukemia Casopis Lekaru Ceskych 131(24-25): 729-732
Jadayel, D.; Calabrese, G.; Min, T.; van Rhee, F.; Swansbury, G.J.; Dyer, M.J.; Maitland, J.; Palka, G.; Catovsky, D. 1995: Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation Leukemia 9(6): 981-987
Valiente, A.; Benítez, J.; Pérez Sáenz, M.A.; Sánchez Fayos, J. 1989: Molecular analysis in 13 cases of chronic Philadelphia-positive myeloid leukemia Sangre 34(6): 481-484
Romanenko, N.A.; Bessmel'tsev, S.S.; Udal'eva, V.I.; Zenina, M.N.; Martynkevich, I.S.; Rugal', V.I.; Abdulkadyrov, K.M. 2013: The combination of chronic myeloid leukemia and multiple myeloma in one patient Voprosy Onkologii 59(2): 103-110
Meloni, G.; Russo, D.; Baccarani, M.; Testoni, N.; Martinelli, G.; Fanin, R.; Zuffa, E.; Rosti, G.; Alimena, G.; Saglio, G.; Mandelli, F.; Tura, S. 1999: A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. the Italian Co-operative Study Group on Chronic Myeloid Leukemia Haematologica 84(8): 707-715
Larripa, I.; Ruiz, Mía.Sol.; Gutiérrez, M.; Bianchini, M. 2017: Guidelines for molecular monitoring of BCR-ABL1 in chronic myeloid leukemia patients by RT-qPCR Medicina 77(1): 61-72
Cervantes, F.; Colomer, D.; Vives-Corrons, J.L.; Rozman, C.; Montserrat, E. 1996: Chronic myeloid leukemia of thrombocythemic onset: a CML subtype with distinct hematological and molecular features? Leukemia 10(7): 1241-1243
Mattei, D.; Saglio, G.; Gottardi, E.; Gallamini, A.; Mordini, N.; Bacigalupo, A. 2001: Persisting molecular remission ten years after donor lymphocyte infusion for hematologic relapse in chronic myeloid leukemia Haematologica 86(5): 545-546
Cannistra, S.A.; Groshek, P.; Griffin, J.D. 1989: Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia Leukemia 3(5): 328-334
Kato, C.; Naoe, T. 2001: Genetic diagnosis of chronic myeloid leukemia Nihon Rinsho. Japanese Journal of Clinical Medicine 59(12): 2336-2341
Lacotte-Thierry, L.; Guilhot, F. 1999: Chronic myeloid leukemia. Diagnosis, course, prognosis La Revue du Praticien 49(3): 339-343
Reiffers, J.; Montastruc, M.; Bilhou-Nabera, C. 1990: Chronic myeloid leukemia. Diagnosis, evolution and prognosis, treatment La Revue du Praticien 40(20): 1879-1885
Sacha, T.; Czekalska, S.; Foryciarz, K.; Zawada, M.; Florek, I.; Cwynar, D.; Wator, G.; Balwierz, W.; Skotnicki, A.B. 2011: H-oCT1 gene expression as a predictor of major and complete molecular response to imatinib of chronic myeloid leukemia. Single center experience Przeglad Lekarski 68(4): 191-195
Casado, L.F.; Picó, M.; Gómez, C.; Ferro, M.T.; Fernández-Rañada, J.M.; Steegmann, J.L. 1997: Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment Medicina Clinica 109(7): 251-255